company background image
524396 logo

Biofil Chemicals and Pharmaceuticals BSE:524396 Stock Report

Last Price

₹60.79

Market Cap

₹997.6m

7D

-7.2%

1Y

29.2%

Updated

19 Jul, 2024

Data

Company Financials

Biofil Chemicals and Pharmaceuticals Limited

BSE:524396 Stock Report

Market Cap: ₹997.6m

Biofil Chemicals and Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Biofil Chemicals and Pharmaceuticals
Historical stock prices
Current Share Price₹60.79
52 Week High₹78.80
52 Week Low₹42.61
Beta2.52
11 Month Change-0.43%
3 Month Change-10.44%
1 Year Change29.18%
33 Year Change-13.47%
5 Year Change724.83%
Change since IPO2,794.76%

Recent News & Updates

Recent updates

Shareholder Returns

524396IN PharmaceuticalsIN Market
7D-7.2%0.9%0.7%
1Y29.2%48.8%44.7%

Return vs Industry: 524396 underperformed the Indian Pharmaceuticals industry which returned 48.8% over the past year.

Return vs Market: 524396 underperformed the Indian Market which returned 44.7% over the past year.

Price Volatility

Is 524396's price volatile compared to industry and market?
524396 volatility
524396 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 524396 has not had significant price volatility in the past 3 months.

Volatility Over Time: 524396's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198547Ramesh Shahwww.biofilgroup.net

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals.

Biofil Chemicals and Pharmaceuticals Limited Fundamentals Summary

How do Biofil Chemicals and Pharmaceuticals's earnings and revenue compare to its market cap?
524396 fundamental statistics
Market cap₹997.58m
Earnings (TTM)₹7.09m
Revenue (TTM)₹400.35m

139.5x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524396 income statement (TTM)
Revenue₹400.35m
Cost of Revenue₹375.08m
Gross Profit₹25.28m
Other Expenses₹18.19m
Earnings₹7.09m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.44
Gross Margin6.31%
Net Profit Margin1.77%
Debt/Equity Ratio2.4%

How did 524396 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.